Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Angocin Anti-Infekt N for MRSA eradication
2014-003024-46Phase 2Terminated
- Sponsor
- Repha
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Methicillin-resistant Staphylococcus aureus colonization (MRSA) and carrier state comparing Angocin Anti-Infekt N with Placebo (2 arms). Started Aug 2014; status: terminated.
02
Drugs
Angocin Anti-Infekt N
03
Conditions
Methicillin-resistant Staphylococcus aureus colonization (MRSA)carrier state
Beyond the preview
Go deeper on 2014-003024-46.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003024-46.